To Our Customers and Colleagues,
I am very pleased to announce that Jack Golabek has been appointed to the position of Chief Executive Officer of Artificial Intelligence In Medicine and will be taking over this role from me on February 1, 2018.
Jack has been with our organization since 1994, serving as Vice President of Engineering for much of that time. A graduate of the University of Toronto’s Faculty of Engineering, Jack entered the real world as an aerospace engineer at de Havilland Boeing Aircraft. A desire for more challenging work led him join AIM in the formative days of artificial intelligence.
There have been enormous changes since then in technology, medicine, business, legislative frameworks, and public and private expectations. In this milieu, Jack was instrumental, and often the leader, in the design, development and implementation of our AI-based products and related software. Although on an industry-wide basis massive resources have been directed towards the development of intelligent systems for healthcare, I believe AIM is one of a small number of firms that succeeded in creating a practical application that is in regular use and provides real productivity-enhancing benefits.
Wider acceptance, indeed demand, for the technology provided AIM the opportunity to be acquired by Inspirata, Inc. which occurred on January 1, 2018. AIM will continue to conduct its business as usual as a functional unit under the Inspirata corporate umbrella. Our Toronto office will become a center of excellence for natural language processing, the branch of artificial intelligence that AIM has focused on and where we have developed our core expertise.
While digital pathology forms the basis of Inspirata’s products, the value of those products is directly related to the information associated with individual patient cases. Natural language processing is thus an essential technology in rendering free text readable by machine.
AIM will continue to market and service its existing products and clients and looks forward to significantly increasing its E-Path Reporter and Abrevio customer base in Canada, the United States and Australia.
I also would like to take this opportunity to introduce Satish Sanan, the Chairman and CEO of Inspirata. Satish has built several successful multi-national software businesses that have garnered him a wealth of technical and commercial experience. Inspirata’s mission is to develop and deliver innovative cancer diagnostic solutions to optimize patient outcomes by identifying the right treatment at the right time for each individual patient.
I will continue to be available to support Jack over the next month or two to ensure that the transition goes smoothly and then I expect to retire from the business. Few people have the good fortune that I have had both professionally and personally, and I am blessed to have been able to serve you. Thank you.

Peter Brueckner
Copyright ©  2018 Artificial Intelligence In Medicine Inc. All rights reserved.
You can unsubscribe from this list here